Triflupromazine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for triflupromazine hydrochloride and what is the scope of patent protection?
Triflupromazine hydrochloride
is the generic ingredient in one branded drug marketed by Apothecon and Bristol Myers Squibb, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for triflupromazine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 243 |
DailyMed Link: | triflupromazine hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for triflupromazine hydrochloride
US Patents and Regulatory Information for triflupromazine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VESPRIN | triflupromazine hydrochloride | TABLET;ORAL | 011123-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Apothecon | VESPRIN | triflupromazine hydrochloride | INJECTABLE;INJECTION | 011325-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | VESPRIN | triflupromazine hydrochloride | TABLET;ORAL | 011123-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |